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RESUMEN
Se sintetizó el 2-ciano-N-(piridin-4-il) acetamida (2) y se-
guidamente fue tratado con cloruros de hidrazonoilo (3) 
para obtener los correspondientes aminopirazoles (5). 
Calentando la mezcla de (2) con benziliden-malononitrilos 
y con benziliden-cianoacetatos de etilo se obtuvieron las 
correspondientes bipiridinas (10) y (16), respectivemente. 
Mediante tratamiento de (2) con fenilisotiocianato en DMF/
KOH seguido por la adición de los cloruros de hidrazonoilo 
(5), (10) apropiados, y de cloroacetato de etilo, se obtu-
vieron los correspondientes 1,2,4-tiadiazoles (22) y (27) y 
1,3-tiazol (24), respectivamente. 
Palabras clave: cianoacetamidas, piridinas, pirazoles, 
1,3,4-tiadiazol, 1,3-thiazoles.
SUMMARY
2-Cyano-N-(pyridin-4-yl)acetamide (2) was prepared and 
then treated with hydrazonoyl chlorides 3 to afford the cor-
responding aminopyrazoles 5. Heating a mixture of 2 with 
benzylidenemalononitriles and with ethyl benzylidenecya-
noacetates afforded the corresponding bipyridines 10 and 
16, respectively. Treatment of 2 with phenylisothiocyanate 
in DMF/KOH followed by addition of the appropriate hy-
drazonoyl chlorides 5, 10 and ethyl chloroacetate gave the 
corresponding 1,2,4-thiadiazoles 22 and 27 and 1,3-thia-
zole 24, respectively. 
Keywords: cyanoacetamides, pyridines, pyrazoles, 
1,3,4-thiadiazole, 1,3-thiazoles.
RESUM
Es va sintetitzar el 2-ciano-N-(piridin-4-il) acetamida (2) i 
seguidament va ser tractat amb clorurs d’hidrazonoil (3) 
per obtenir els corresponents aminopirazols (5). Escalfant 
la barreja de (2) amb benziliden-malononitrils i amb benzi-
liden-cianoacetats d’etil es van obtenir les corresponents 
bipiridines (10) i (16), respectivement. Mitjançant tracta-
ment de (2) amb fenilisotiocianat en DMF/KOH seguit per 
l’addició dels clorurs d’hidrazonoilo (5), (10) apropiats, i de 
cloracetat d’etil, es van obtenir els corresponents 1,2,4-ti-
adiazols (22) i (27) i 1,3-tiazol (24), respectivament. 
Paraules clau: cianoacetamides, piridines, pirazols, 
1,3,4-tiadiazol, 1,3-thiazols.
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1.  INTRODUCTION
Pyridine derivatives are among the most used frameworks 
for medicines, food flavorings, dyes and agrochemicals.1 
They were found to have antitumor,2 anticonvulsant and 
anti-inflammatory,3 and antiproliferative4 activities. Pyr-
azole derivatives have important applications in the field of 
medicinal chemistry and pharmacueticals.5-9 Cyanoacet-
amide derivatives have been found to be useful as her-
bicidals10 and to be active against neoplastic disorder.11 
Furthermore, they have also been important for their an-
tiinflammatory,12 antibacterial,13,14 antitumor,15 neoplasm 
inhibitory,16 tyrosine kinase inhibitory,17 and analgesic 
properties,18 and for the treatment of disorders related to 
vasculogenesis.19 1,3,4-Thiadiazoles were recently report-
ed by us and others as highly anti-inflammatory,20,21 anti-
convulsant20,22 and antiviral23 agents. In continuation to our 
research work on 1,3,4-thiadiazole derivatives.24-32  In the 
course of our investigations, we found that the hitherto un-
reported 2-cyano-N-(pyridin-4-yl)acetamide (2) is a highly 
versatile building block for the synthesis of a wide variety 
of several new pyridine-based heterocyclic derivatives.
2.  RESULTS AND DISCUSSION
Heating a mixture of 4-aminopyridine (1) and ethyl cyano-
acetate at 110-120 °C without solvent resulted in the for-
mation of the novel 2-cyano-N-(pyridin-4-yl)acetamide (2) 
in a good yield (Scheme 1). The IR spectrum of the reac-
tion product showed three absorption bands at 3348 (NH), 
2193 (C≡N), 1637 (C=O) cm-1. Mass spectrum showed a 
peak at m/e 161 due to the molecular ion of the product 
2. The assignment is also based on the presence of four 
signals (CH2, two CH’s and NH) in 1H NMR spectrum of 
the reaction product. Treatment of 2-cyano-N-(pyridin-4-yl)
acetamide (2) with the hydrazonoyl chloride 3a in ethanolic 
sodium ethoxide solution at room temperature furnished a 
single product for which the two possible structures 5 and 





























































However, spectral data were in complete accordance with 
the aminopyrazole structure 5. The IR spectrum of the reac-
tion product was free of any nitrile function and showed ab-
sorption bands at 3443, 3331, 3042, 1670 and 1638 cm-1 
due to amino, amide-NH and two carbonyl groups, respec-
tively. Moreover, the mass spectrum of the isolated product 
revealed a molecular ion peak at m/z 321. The obtained 
data gave a firm support for the aminopyrazole derivative 5 
and excluded the other possible cyanopyrazole derivative 
6. A plausible mechanism of the formation of compound 5 
is outlined in Scheme 1.
Next, when equimolar amounts of the cyanoacetamide de-
rivative 2 and benzylidenemalononitrile 7a were refluxed 
in the presence of a catalytic amount of piperidine,it af-
forded a single product proved to be a 1 : 1 cycloadduct. 
The structure of the isolated product was identified as 
6-amino-1,2-dihydro-2-oxo-4-phenyl-1-(pyridin-4-yl)pyri-
dine-3,5-dicarbonitrile 10a (Scheme 3) on the basis of its 
spectral data. Structure 10a is assumed to be formed via 
an initial Michael-type adduct 8a followed by an intramo-
lecular cyclization and subsequent oxidation to give the 


























7-11:  a,  Ar = C6H5 


















The other expected product 11a via loss of hydrogen cya-
nide was not detected on the basis of the mass spectrum 
of the reaction product. Furthermore, when equimolar 
amounts of 2 and 4-chlorobenzylidenemalononitrile 7b 
were refluxed under the same reaction condition above, it 
afforded the 1-(pyridin-4-yl)pyridine-3,5-dicarbonitrile de-
rivative 10b (Scheme 2) based on the spectral data of the 
isolated product.
When 2-cyano-N-(pyridin-4-yl)acetamide (2) was treated 
with ethyl benzylidenecyanoacetate 12a in refluxing ethanol, 
in the presence of a catalytic amount of piperidine, it gave 
the corresponding 1,4’-bipyridine derivative 16 as outlined 















































12-17:  a,  Ar = C6H5 







- H2 - EtOH
CNCN
Compound 16 was formed initially via a Michael-type addi-
tion to give the intermediate 13a followed by elimination of 
ethanol molecule to give the intermediate 14a then of hydro-
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gen under the reaction condition to give the 1,4’-bipyridine 
derivative 16. The absence of aliphatic-CH protons in the 1H 
NMR spectrum supports structure 16 which is the tautomer 
of 15. The absence of absorption bands due to NH2 in the 
IR spectrum and the ester-protons in the 1H NMR spec-
trum of the reaction product ruled out structure 17. Similarly, 
compound 2 reacted with ethyl 4-chlorobenzylidenecyano-
acetate 12b under the same reaction conditions to give the 
4-(4-chlorophenyl)-1-(pyridin-4-yl)pyridine-3,5-dicarbonitrile 
16b (Scheme 3) on the basis of  the elemental analyses and 
spectral data of the isolated product.
Next, the synthesis of some pyridine-based 1,3,4-thiadia-
zole derivatives is attempted. Thus, treatment of 2-cyano-
N-(pyridin-4-yl)acetamide (2) with phenyl isothiocyanate in 
dimethyl formamide, in the presence of potassium hydrox-
ide, at room temperature gave the non-isolable interme-
diate potssium salt 18 as shown in Scheme 4. Addition 
of an equimolar amount of the hydrazonoyl chloride 19 
furnished only one isolable product which was identified 
as the 2-cyano-N-(pyridin-4-yl)-2-[3,5-diphenyl-2(3H)-
1,3,4-thiadiazolylidene]acetamide 22 as confirmed by the 
spectroscopic analyses (IR, 1H NMR and MS spectra) of 
the isolated product. The formation of the thiadiazole de-
rivative 22 indicates that the reaction proceeds via loss of 
potassium chloride and aniline from the intermediates 20 
and  21, respectively. Next, treatment of the intermediate 
2, formed in situ under the same reaction condition, with 
ethyl chloroacetate afforded a single product identified 
as 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-
(pyridin-4-yl)acetamide (24) as shown in Scheme 4. Its 1H 
NMR spectrum revealed two singlets at d 4.07 and 11.30 
due to thiazolidinone-CH2 and NH protons in addition to 
aromatic multiplets signal at d 8.05-8.55. The obtained 
















































































In a similar manner, reaction of the hydrazonoyl chloride 3a 
with the potassium salt 18 under the same reaction con-
dition gave the assigned structure 2-[5-acetyl-3-phenyl-
1,3,4-thiadiazol-2(3H)-ylidene)-2-cyano-N-(pyridin-4-yl)
acetamide 27a (Scheme 5) and the other structures 28a, 
29a were excluded based on the elemental and spectro-
scopic data of the reaction product. In addition, treatment 
of C–acetyl-N-(4-tolyl)hydrazonoyl chloride 3c with the 
intermediate salt 18 gave similarily only one product for 
which structures 27b-29b can be assigned as outlined in 
Scheme 5. However, spectral data of the reaction product 
were in complete accordance with structure 27b. The IR 
spectrum of the reaction product revealed the presence of 
two carbonyl absorptions which excludes structures 28b 
and 29b. Also, 1H NMR spectrum of 27b showed two sin-
glets at d 2.28 and 2.44 due to 4-CH3 and COCH3 protons 
in addition to the aromatic multiplets at d 7.07–8.43 and a 
broad singlet at d 11.22 for NH proton. The presence of the 
two singlets due to two CH3-protons confirms the loss of 
aniline and not p-toluidine from the intermediate 26b. The 
























































26--28 : a; Ar = C6H5




3.  EXPERIMENTAL SECTION
All melting points were measured on a Gallenkamp elec-
trothermal melting point apparatus. The infrared spectra 
were recorded for potassium bromide pellets on a Pye 
Unicam SP 3-300 and FT IR 8101 PC Schimadzu infra-
red spectrophotometers. The 1H NMR spectra were re-
corded in deuterated chloroform or dimethyl sulfoxide at 
300 MHz on a Varian Mercury NMR spectrometers using 
tetramethylsilane as an internal reference. Mass spectra 
were recorded on a GCMS–QP 1000 EX Shimadzu mass 
spectrometer at 70 eV. Hydrazonoyl chlorides 2a,33 2b,c34 
and 1935 arylmethylenepropane dinitrile 7a,b36 and ethyl 
benzylidenecyanoacetate 12a,b36 were prepared following 
literature procedures.
3.1. Synthesis of 2-cyano-n-(pyridin-4-yl)acetamide (2) 
In a 100 mL three-necked round–bottomed flask, fitted 
with air condenser and thermometer were placed ethyl 
cyanoacetate (2.26 g, 2.1 ml, 20 mmol). The flask was im-
mersed in an oil bath heated to 110-120 oC then 4-ami-
nopyridine (1.9 g, 20 mmol) was added portion-wise over 
a period of 30 min. and heating was continued for an ad-
ditional 3 min. The reaction flask was removed from the oil 
bath, left to cool and triturated with methanol. The solid 
product was filtered off washed with ethanol several times 
and dried.  Recrystallization from ethanol afforded yellow-
ish-white crystals of 2 in 65% yield. Mp. 242-244 oC; IR u 
(cm-1): 3348 (NH), 2193 (C≡N), 1637 (C=O), 1520 (C=N); 1H 
NMR (DMSO-d6) d 3.89 (s, 2H, CH2), 8.01 (d, 2H, J = 7.2 
Hz), 8.53 (d, 2H, J = 7.2 Hz), 11.73 (s, 1H, NH); 13C NMR 
(DMSO-d6) d 28.7, 108.7, 112.9, 149.7, 159.5, 178.9; MS 
m/z (%) 161 (M+, 76.6), 121 (37.6), 94 (100), 78 (86.3). Anal. 
for C8H7N3O Calcd: C, 59.62; H, 4.38; N, 26.07. Found: C, 
60.01; H, 4.17; N, 26.12%. 
3.2. 3-Acetyl-5-amino-1-aryl-n-(pyridin-4-yl)-1H-pyr-
azole-4-carboxamides 5.
2-Cyano-N-(pyridin-4-yl)acetamide (2) (0.322 g, 2 mmol) 
was added  to an ethanolic sodium ethoxide solution [pre-
pared from sodium metal (46 mg, 2 mmol) and absolute 
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ethanol (20 mL)] with stirring. After stirring the resulting so-
lution for 15 min., the appropriate hydrazonoyl halide 3a,b 
(2 mmol) was added portion-wise and the reaction mixture 
was stirred for further 12h at room temperature. The solid 
that formed was filtered off, washed with water and dried. 
Recrystallization from ethanol afforded the corresponding 
pyrazole derivatives 5a,b in 55-61% yields. 
3-Acetyl-5-amino-1-phenyl-N-(pyridin-4-yl)-1H-pyr-
azole-4-carboxamide (5a)
Yield (61%), mp. 173-175 oC; IR (KBr) u 3414, 3330, 3110 
(NH2, NH), 1670, 1621 (2 C=O) cm
-1; 1H NMR (CDCl3) d 2.41 
(s, 3H, COCH3), 7.09-7.63 (m, 9H, ArH), 8.15 (s, 1H, D2O-
exchangeable, NH), 8.45 (s, 2H, D2O-exchangeable, NH2); 
MS m/z (%) 322 (M++1, 7.8), 321 (M+, 42.9), 278 (14.3), 
228 (100), 160 (24.7), 135 (46.8), 119 (27.3), 104 (44.2), 
95 (18.2), 77 (92.2), 51 (63.6). Anal. Calcd. for C17H15N5O2: 




Yield (55%); mp. 164-166 oC; IR (KBr) u 3418, 3310, 3132 
(NH2, NH), 1674, 1655 (2C=O) cm
-1; 1H NMR (CDCl3) d 2.44 
(s, 3H, CH3), 2.71 (s, 3H, COCH3), 5.99 (s, 2H, NH2), 6.96 
(m, 1H), 7.34-7.49 (m, 5H), 8.27 (d, 1H, J = 8.4 Hz), 8.4 (d, 
1H, J = 5.8 Hz), 12.45 (s, 1H, NH); 13C NMR (CDCl3) d 20.7, 
26.8, 95.8, 113.5, 119.1, 124.5, 130.1, 134.3, 138, 138.5, 
145.9, 148.1, 152, 153.1, 162.3, 198.2; MS m/z (%) 335 
(M+, 28.6), 292 (100), 242 (88.9), 91 (21.6). Anal. Calcd for 
C18H17N5O2: C, 64.47; H, 5.11; N, 20.88. Found: C, 64.51; 
H, 5.15; N, 20.79%. 
3.3.  6-Amino-4-aryl-1,2-dihydro-2-oxo-1-(pyridin-4-yl)
pyridine-3,5-dicarbonitrile 10
To a solution of the appropriate arylmethylenepropanedini-
trile  7a,b (5 mmol) in ethanol (20 mL) was added 2-cyano-
N-(pyridin-4-yl)acetamide (2) (0.81 g, 5 mmol), and few 
drops of piperidine and the reaction mixture was heated 
under reflux for 4h, then left to cool to room temperature. 
The solid product that formed was collected by filtration, 
washed with ethanol and then recrystallized from DMF/
water to give the 1,4-bipyridine derivatives 10a,b.                          
6-Amino-1,2-dihydro-2-oxo-4-phenyl-1-(pyridin-4-yl)
pyridine-3,5-dicarbonitrile (10a): Yield (66%), mp. > 300 
oC (DMF); IR (KBr) u 3356 and 3153 (NH2), 2205 (C≡N), 
1698 (C=O), 1636 (C=N), 1528 (C=C) cm-1; 1H NMR (DMSO) 
d 7.51-7.60 (m, 7H, ArH), 8.05 (br. s, 2H, NH2), 8.51 (d, 2H, 
J = 6 Hz, ArH); MS m/z (%) 314 (M++1, 24.7), 313 (M+, 78), 
285 (27.7), 209 (8.0), 156 (10.4), 120 (8.9), 104 (12.8), 78 
(62.2), 51 (100). Anal. Calcd for C18H11N5O: C, 69.00; H, 
3.54; N, 22.35. Found: C, 69.24; H, 3.45; N, 22.18%. 
6-Amino-4-(4-chlorophenyl)-1,2-dihydro-2-oxo-1-
(pyridin-4-yl)pyridine-3,5-dicarbonitrile (10b): Yield 
(74%), mp. > 300 oC (DMF); IR (KBr) u 3343 and 3166 
(NH2), 2220 (C≡N), 1679 (C=O), 1625 (C=N), 1520 (C=C) 
cm-1; 1H NMR (DMSO) d 7.49 (d, 2H, J = 6 Hz, ArH), 7.56 (d, 
2H, J = 8.4 Hz, ArH), 7.68 (d, 2H, J = 8.4 Hz, ArH), 8.10 (br. 
s, 2H, NH2), 8.82 (d, 2H, J = 6 Hz, ArH); 
13C NMR (DMSO) d 
75.6, 88.1, 115.3, 115.8, 123.8, 128.8, 129.8, 133.4, 135.2, 
141.8, 151.9, 156.5, 158.8, 160.4; MS m/z (%) 349 (M++2, 
24.5), 348 (M++1, 16.4), 347 (M+, 51.0), 319 (23.0), 284 
(6.6), 243 (8.8), 180 (12.4), 156 (5.8), 120 (10.1), 105 (6.6), 
78 (69.4), 51 (100). Anal. Calcd for C18H10ClN5O: C, 62.17; 
H, 2.90; N, 20.14. Found: C, 62.04; H, 2.85; N, 20.21%. 
3.4. Reaction of the cyanoacetamide 2 with ethyl ben-
zylidenecyanoacetates 12a,b.
To a solution of the appropriate ethyl benzylidenecya-
noacetate 12a,b (5 mmol) in ethanol (20 mL) was added 
2-cyano-N-(pyridin-4-yl)acetamide (2) (0.81 g, 5 mmol), 
and few drops of piperidine and the reaction mixture was 
heated under reflux for 4h, then left to cool to room tem-
perature. The solid product that formed was collected by 
filtration, washed with ethanol and then recrystallized from 
DMF/water to give brownish-white solid of the correspon-
ding 1,4-bipyridine derivatives 16a,b.
6-Hydroxy-2-oxo-4-phenyl-1-(pyridin-4-yl)pyridi-
ne-3,5-dicarbonitrile (16a):
Yield (82%), mp. 258-260 oC; IR (KBr) u 3419 (OH), 2212 
(C≡N), 1626 (C=O) cm-1; 1H NMR (DMSO) d 7.44-7.87 (m, 
ArH); 13C NMR (DMSO-d6) d 95.6, 119.8, 128.6, 128.8, 
128.9, 129.1, 130.3, 130.8, 133.6, 136.5, 146.3, 148.8, 
168; MS m/z (%) 314 (M+, 11.5), 247 (40.4), 173 (11.5), 
160 (59.6), 149 (30.8), 121 (44.2), 118 (46.2), 104 (38.5), 
94 (100), 78 (73.1), 67 (63.5). Anal. Calcd for C18H10N4O2 




Yield (60%), mp. > 300 oC; IR (KBr): u 3425 (OH), 2204 
(C≡N), 1650 (C=O) cm-1; 1H NMR (DMSO) d 4.31 (br. s, 1H, 
OH), 7.31-7.68 (m, 6H, ArH), 8.06 (d, 2H, J = 6.9 Hz); MS: 
m/z (%) 348 (M+, 30.8), 284 (15.4), 236 (48.7), 188 (17.9), 
164 (17.9), 156 (15.4), 94 (59.0), 51 (100). Anal. Calcd for 
C18H9ClN4O2 (348.75): C, 61.99; H, 2.60; N, 16.07. Found: 
C, 62.07; H, 2.49; N, 16.11%.
3.5.  Synthesis of 1,3,4-thiadiazole derivatives 22 and 27.
To a stirred solution of potassium hydroxide (0.11 g, 2 
mmol) in dimethylformamide (20 mL) was added 2-cyano-
N-(pyridin-4-yl)acetamide (2) (0.322 g, 2 mmol). After stir-
ring for 30 min, phenylisothiocyanate (0.27 g, 2 mmol) was 
added to the resulting mixture. Stirring was continued for 
6h, then the appropriate hydrazonoyl chlorides 3 or 19a,b 
(2 mmol) were added portionwise over a period of 30 min. 
After the addition was complete, the reaction mixture was 
stirred for additional 12h, during which reactants dis-
solved and a yellowish–red colored product precipitated. 
The solid product was filtered off, washed with water and 
dried. Recrystallization from the suitable solvent afforded 
the corresponding products 1,3,4-thiadiazole derivatives 
22 and 27a,b respectively.
2-Cyano-2-[3,5-diphenyl)-2(3H)-1,3,4-thiazolylidene]-
n-(pyridin-4-yl)acetamide (22).
Yellowish-white powder; yield (81%); m.p. > 300 oC (DMF/
H2O), IR u 3412 (NH), 2185 (C≡N), 1633 (C=O), 1594 (C=N) 
cm-1; 1H NMR (DMSO-d6) d 7.19–8.40 (m, 14H, ArH), 9.97 
(br.s, 1H, NH); MS m/z (%) 397 (M+, 43.8), 304 (100), 173 
(14.9), 169 (34.7), 146 (37.2), 109 (19), 77 (49.6). Anal. for 
C22H15N5OS Calcd: C, 66.48; H, 3.80; N, 17.62;  S, 8.07. 
Fund: C, 66.38; H, 3.97; N, 18.02; S, 17.46%.
2-(5-Acetyl-3-p-tolyl-1,3,4-thiadiazol-2(3H)-ylidene)-
2-cyano-n-(pyridin-4-yl)acetamide (27a).
Yield (67%); Mp: 206-206 oC (DMF/H2O), IR u 3416 (NH), 
2192 (C≡N), 1644 (C=O), 1532 (C=N) cm-1; 1H NMR (DM-
SO-d6) d 2.28 (s, 3H, p-CH3), 2.44 (s, 3H, COCH3), 7.20–
8.43 (m, 8H, ArH), 11.21 (s, 1H, NH); 13C NMR (DMSO-d6) d 
20.38, 25.0, 80.0, 114.8, 115.3, 122.8, 128.1, 129.9, 132.9, 
139.4, 140.4, 144.5, 155.4, 165.1, 194.3; MS m/z (%) 377 
(M+, 10.2), 291 (3.2), 261 (73.1), 208 (32.3), 165 (7.0), 132 
(27.4), 106 (100), 77 (57.0). Anal. for C19H15N5O2S Calcd: C, 
60.46; H, 4.01; N, 18.56; S, 8.50. Found: C, 60.31; H, 3.88; 
N, 18.42; S, 8.69%. 
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2-(5-Acetyl-3-phenyl-1,3,4-thiadiazol-2(3H)-ylidene)-
2-cyano-n-(pyridin-4-yl)acetamide (27b).
Yield (70%); Mp. 165-168 oC (DMF/H2O), IR u 3416 (NH), 
2190 (C≡N), 1649 (C=O), 1611 (C=N) cm-1; 1H NMR (DM-
SO-d6) d 2.45 (s, 3H, COCH3), 7.08–7.68 (m, 9H, ArH), 
11.18 (s, 1H, NH); 13C NMR (DMSO-d6) d 25.2, 80, 115.4, 
121.2, 122.1, 124.1, 128.6, 129.1, 129.3, 129.7, 136.2, 
141.6, 144.7, 152.6, 196.0; MS m/z (%) 363 (M+, 4.5), 247 
(51.7), 205 (14.7), 194 (21.8), 118 (100), 92 (75.2), 77 (66.8). 
Anal. for C18H13N5O2S Calcd: C, 59.49; H, 3.61; N, 19.27; S, 
8.82. Found: C, 59.31; H, 3.68; N, 19.14; S, 8.67%. 
3.6. Synthesis of Synthesis of 1,3-thiazolidine deriva-
tive 24.
The above procedure was repeated using ethyl chlo-
roacetate (2 mmol) instead of the hydrazonoyl chlorides 
3 and 19a,b. The reaction mixture was then heated at re-
flux for 6h, during which reactants were dissolved and a 
yellowish–red colored product was precipitated. The so-
lid product was filtered off, washed with water and dried. 
Recrystallization from the DMF/water afforded 2-cyano-
2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-(pyridin-4-yl)
acetamide (24) in 81% yield; Mp 268-270 oC, IR u 3179 
(NH), 1719 (C=O), 1622 (C=N) cm-1; 1H NMR (DMSO-d6) 
d 4.07 (s, 2H, CH2), 7.84–8.55 (m, 9H, ArH), 11.30 (s, 1H, 
NH). Anal. for C17H12N4O2S (336.38).Calcd: C, 60.70; H, 
3.60; N, 16.66; S, 9.53. Found: C, 60.51; H, 3.45; N, 16.39; 
S, 9.42%. 
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